DeliveryAre people holding MAXHEALTH or just trading it?
Daily delivery ▲
49.9%
-0.8σ
Weekly delivery ▲
56.1%
+0.2σ
Monthly delivery ▲
58.3%
-0.6σ
Delivery against its own usual level
Period
Delivery
Its usual
Reading
Last session
49.9%
58.2%
14% below · in its usual range
Last 5 sessions
54.8%
57.3%
4% below · in its usual range
Last 21 sessions
57.8%
55.7%
4% above · in its usual range
"Its usual" is the plain average of the sessions just before: 20 for the last session, 21 for the last 5, 63 for the last 21. A delivery fact, not a record of who traded.
Trading activityHow busy was trading in MAXHEALTH, and how large were the trades?
Session VWAP
₹944.91
Close +0.23% vs VWAP
Avg Trade Size
₹27,153
0.72x vs normal
Turnover
0.43x
vs 20-day avg
Volume contracting (0.4x avg) — no conviction in the current direction.
BEFOREwhat has already happened
Who is addingWho has been adding to MAXHEALTH, and who has been reducing?
SMART MONEY Delivery was 49.9% on 13-Nov-26, against about 56% on a usual day.
Smart Money @ price level and date
Date
Price level
Delivery
Day
29-Oct-26
₹851.15
71.0%
▼
28-Oct-26
₹851.50
75.5%
▲
16-Oct-26
₹846.00
67.1%
▼
08-Sep-26
₹993.00
67.5%
▲
Days when delivery was well above its own 60-day average. A delivery fact, not a record of who traded.
Foreign investors (FII) have been net sellers for 5 straight quarters, while domestic mutual funds (DII) have been net buyers for 5 straight quarters — domestic money stepping in as foreign money steps out.
Promoter23.7%→ flat
FII40.5% ↓1.3%5Q down
DII31.0% ↑1.1%5Q up
Public4.8% ↑0.2%
DII Holders10 →↑4↓1+1new−1exit
Dec'23Sep'26
■ Prom■ FII■ DII■ Pub
FII and DII, year on year
Period
FII
DII
Delta FII + DII
Last 12 months (Sep'25 → Sep'26)
51.8% → 40.5% (−11.3 pts)
20.0% → 31.0% (+11.0 pts)
71.8% → 71.5% (−0.3 pts)
FY26 (Mar'25 → Mar'26)
54.7% → 45.4% (−9.3 pts)
17.6% → 26.3% (+8.7 pts)
72.3% → 71.7% (−0.6 pts)
FY25 (Mar'24 → Mar'25)
57.3% → 54.7% (−2.6 pts)
15.0% → 17.6% (+2.6 pts)
72.3% → 72.3% (+0.0 pts)
FY24 (Mar'23 → Mar'24)
52.0% → 57.3% (+5.3 pts)
19.4% → 15.0% (−4.4 pts)
71.4% → 72.3% (+0.9 pts)
View all 12 quarters
Quarter
FII %
DII %
Dec 2023
60.7
11.6
Mar 2024
57.3
15.0
Jun 2024
57.0
15.4
Sep 2024
57.3
15.1
Dec 2024
56.9
15.6
Mar 2025
54.7
17.6
Jun 2025
54.8
17.4
Sep 2025
51.8
20.0
Dec 2025
50.5
21.2
Mar 2026
45.4
26.3
Jun 2026
41.8
29.9
Sep 2026
40.5
31.0
Domestic Institutional Holders Jun 2026 → Sep 202610 inst.
Total holders10 (+0)
Increasing stake↑ 4
Decreasing stake↓ 1
New entrants+ 1
Full exits− 1
Unchanged 4
Promoter pledge: none (16-Oct-2026).
Recent block deals
None recorded in the stored window.
AHEADlevels that matter, not forecasts
Price levelsAt what prices have buyers and sellers shown up before?
✓Golden Cross (lagging): the 50-day EMA crossed above the 200-day EMA, but the shorter-term EMAs are not yet aligned — the cross is present but not yet structural.
✓Index-wide FII flow BULLISH — foreign institutions net buying (+47,093 Cr 5d net): macro tailwind — Max Healthcare Institute Ltd's own FII shareholding is trending down, a separate signal from the index-wide flow above.
✓Operating margin expanding +4.7pp (3yr vs prior 3yr) — within the common range for genuine improvement
🕯 Pattern
✓Fibonacci Support: nearest Fibonacci level is 1.3% below current price (at 935). Price resting just above a Fibonacci retracement is a common support level in a continuing trend — institutions watch these levels.
✓OI long buildup ↑
CONTRADICTING / RISKS
📊 Price & Structure
✗Not near identified demand zone
📦 Volume & Flow
✗Volume Profile Resistance: High-Volume Node within 3% above current price. Traders who bought at this high-volume zone and are underwater will use any rally into it as a breakeven-exit opportunity — creating a structural ceiling until volume absorbs the overhang.
✗P/E 61.5x — elevated due to earnings trough typical of turnaround setups; watch for normalization as earnings recover
FII reducing significantly (-1.3% QoQ). Watch for FII trend to stabilise before treating this as a high-conviction bottom. Relative strength: bottom 33% of stocks over 6 months — historically the weakest 40% lagged the rest in 60% of months, so the bottom reading here needs confirmation. About this label: it describes the chart pattern. In a test of 2020–2026 that used only what was known at each date, stocks with bottom labels like this more often did worse than other stocks over the next 3–6 months, so it is not a buy signal on its own.
Want to see how the company behind MAXHEALTH is doing, and its price levels in detail?Look closer ↓
●●○LOOK CLOSERabout 2 minutes
Company health and price tables, terms explained.
Company healthHow are MAXHEALTH's profit, debt, returns and growth?
Returns and safety
Return on Equity
15%
ROCE
15%
Debt / Equity
0.34x
CFO/EBITDA
55%
Growth and trend
Rev 5yr CAGR
+27%
Profit 5yr CAGR
+60%
Margin 3v3yr
+4.7pp
Debt Trend
+0.20x
Cash-Flow Stage
Growth
CFO / CFI / CFF
+ / − / +
Value
Market value
₹87,324 Cr
P/E
61.5x
P/E vs Own 5yr Med
0.95x
P/B Ratio
8.2x
Price and ownership data cannot show problems in a company's accounts or governance, so a stock can look cheap and still be in trouble. Check the filings.
Levels in detailWhich support, resistance and average levels are there?
Key Levels — tested support & resistance
Type
Level
Distance
Tests ⓘ
Strength
Resistance
₹1,073
+13.3%
1
4.6
Resistance
₹1,185
+25.2%
1
3.0
Resistance
₹1,256
+32.6%
1
4.2
Support
₹797
-15.8%
1
3.2
ⓘ Tests = approach episodes counted from each zone's own formation date.
A deeper zone formed earlier can have more tests than a shallower zone formed recently — this is expected.
EMA Trend Regime — ribbon & dynamic levels
ImmediateStrong Up
Mid-termDown (weakening)
Long-termDown
EMA
Level
Distance
EMA 10 (immediate)
₹917.7
+3.2%
EMA 21 (immediate/mid)
₹905.3
+4.6%
EMA 63 (mid/long)
₹944.2
+0.3%
EMA 200 (long-term)
₹1,007.7
-6.0%
LOW CONFIDENCE
Hurst 0.56 (trending) · ADX 28 (strong trend) — both required above threshold for HIGH confidence
EMA = an average that counts recent prices more.
●●●ANALYST VIEWfor experts
Every indicator and score, in the usual technical terms.
ScoresHow do the engine’s scores read for MAXHEALTH?
Bottom turn zone
18 / 100
How many signs point to a bottom forming.
Peak turn zone
11 / 100
How many signs point to a top forming.
Institutional quality
23 / 100
How strong big-investor activity looks.
Coil energy
24 / 150
forming
How tightly the price has been compressing.
Momentum
26 / 100
weak · lowest 26% of 147 largecaps
How strongly the price has moved against its peers.
Relative strength vs Nifty 50
−8.6% over the quarter
weakening · 20-day slope falling
How the stock has done against the Nifty 50.
Technical indicatorsWhat do the popular indicators (RSI, MACD, volume) show?
TREND
10-day averageprice is 3.2% above it
₹918
21-day averageprice is 4.6% above it
₹905
63-day averageprice is 0.3% above it
₹944
200-day averageprice is 6.0% below it
₹1,008
50-day vs 200-day average50-day is below the 200-day (death-cross state), since 01-Oct-26
MACD (12, 26, 9) dailymomentum is stronger than its 9-period average
histogram +14.6
MACD (12, 26, 9) weeklymomentum is weaker than its 9-period average
histogram −9.1
Stochastic (14, 3, 3)high (overbought zone)
95
Williams %R (14)high zone
−4
CCI (20)above +100: stretched up
118
Rate of change (12 days)price is higher than 12 days ago
+12.1%
VOLUME AND FLOW
Money Flow Index (14)middle range
80
Chaikin Money Flow (20)more volume on closes near the high
+0.128
On-balance volumevolume has been flowing in on up days
above its 20-day average
Elder Force Index (13)buyers are driving the move
positive
Volume vs 20-day averagequieter than usual
0.4×
VOLATILITY
Average daily range (ATR 14)wider than 32% of the past year's days
2.8% of price
Bollinger bands (20, 2)near the upper band · width 21.3%
%B 87
20-day volatility (yearly rate)how much the price has been swinging
24%
Narrowest range of 7 days (NR7)the last session's range is wider than the narrowest of the last 7
no
Volatility contraction (VCP)no contraction: recent ranges are not unusually even
ratio 0.86
60-day volatility percentile60-day swings wider than 83% of the past year's days
83%
Common settings (RSI 70/30, Stochastic and MFI 80/20). A reading, not a signal. Green dot: supports the bullish side. Red dot: supports the bearish side. Grey: neutral. Amber: stretched high zone. Blue: stretched low zone. Direction follows each indicator’s standard rule.
COMMON QUESTIONSanswers in plain words
MAXHEALTH share price: closing price on 13-11 and how it has moved
MAXHEALTH closed at ₹947.10 on 13-11 (+0.1%). Over the week +1.6%, past month +10.0%, past year −15.8%.
MAXHEALTH 52-week high and low
MAXHEALTH's 52-week high is ₹1,185.40 and its 52-week low is ₹797.00. The 13-11 close of ₹947.10 is 38% of the way up that range and 20.1% below the 52-week high.
MAXHEALTH P/E ratio: what is it and how does it compare with its own past?
MAXHEALTH's P/E is 61.5x on 13-11 (P/B 8.2x), which is 0.95x its own 5-year median of 65x. A P/E on its own does not say what happens next.
MAXHEALTH shareholding pattern: promoter, FII, DII and public holding
As of the Sep 2026 quarter-end promoters hold 23.7% (unchanged) of MAXHEALTH, FIIs 40.5% (−1.3 points), DIIs 31.0% (+1.1 points) and the public 4.8%. Promoter pledge: none (16-Oct-2026).
MAXHEALTH support and resistance levels
Nearest resistance zone: ₹1,060.74–₹1,072.60 (12.0% above the 13-11 close, tested 1× before). Nearest support zone: ₹797.00–₹811.09 (14.4% below the 13-11 close, tested 1× before). These are prices where the stock has stalled or turned before, not forecasts.
Should I buy MAXHEALTH? What the data shows
Zonters does not give buy or sell recommendations, price targets, or personal advice. The facts on 13-11: MAXHEALTH is 38% of the way up its 52-week range and 27.9% below its 10-year high; P/E 0.95x its 5-year median; FIIs cut their holding by 1.3 points last quarter; delivery 49.9% against about 56% normal. For a decision, speak to a SEBI-registered investment adviser.
Why did MAXHEALTH share price rise on 13-11?
MAXHEALTH rose 0.1% to ₹947.10 on 13-11, on volume 0.4× its usual, with delivery at 49.9% (about 56% is normal). The Nifty moved −0.6% the same day. Its sector, HEALTHCARE, ranks 11 of 18 on 6-month strength (leading). Zonters shows what the data did, not news or results.
MAXHEALTH delivery percentage and heavy-delivery days
MAXHEALTH's delivery was 49.9% on 13-11, 56.1% over the last complete week and 58.3% over the last complete month, against a 60-day normal of about 56%. Delivery is the share of traded shares taken into investors' accounts instead of being closed out the same day. Heavy-delivery days (date, price, delivery): 29-10-26 ₹851.15 (71.0%); 28-10-26 ₹851.50 (75.5%); 16-10-26 ₹846.00 (67.1%).
MAXHEALTH vs Nifty 50 and vs its sector
To 13-11: 1 month MAXHEALTH +10.0% vs Nifty +11.1% (gap 1.1 points behind); 3 months MAXHEALTH −6.0% vs Nifty +3.1% (gap 9.1 points behind); 1 year MAXHEALTH −15.8% vs Nifty −1.7% (gap 14.2 points behind). Its sector, HEALTHCARE, ranks 11 of 18 on 6-month strength (leading).
MAXHEALTH all-time high and worst fall
MAXHEALTH is 27.9% below its 10-year high on 13-11. Its worst fall of 10% or more in the 6 years of data (since 04-09-20) was 37% from 03-07-25 to 23-10-26; the old high has not been regained.
FACT SHEET — exact values from the Zonters engine; all prices are last closes
Stock:Max Healthcare Institute Ltd (MAXHEALTH)
Data as of (last trading session):13-11-2026
Price (last close):closed at ₹947.10 on 13-11 (+0.1% on the previous close)
Change:last session (13-11) +0.1% · this week +1.6% · past month +10.0%
52-week range:₹797.00 to ₹1,185.40
Position in 52-week range:38% (in the middle; 0% = the low, 100% = the high)
Returns:YTD -9.4% · 1Y -15.8% · 3Y +63.9% · 5Y +172.6% · From 10-yr high -27.9%